PROGRAM & SPEAKERS:
Chaired by Katja Pokrovskaja Tamm and Angelo De Milito
09:00 – 09:10 Dan Grandér, Chair Dep. Oncology-Pathology, Karolinska Institutet Jessica Martinsson, Sprint Bioscience Welcome
09:10 – 09:30 Anders Lönnberg, Swedish Government National Coordinator for Life Science.
09:30 – 10:00 Ravi Amaravadi, University of Pennsylvania, PhiladelphiaTargeting the lysosome in the tumor microenvironment
10:00 – 10:30 Bassam Janji, Luxembourg Institute of Health, Luxembourg Impact of targeting autophagy on the immune landscape of melanoma
10:30 – 11:00 Randall Johnson, Karolinska Institutet The role of hypoxia in cytotoxic T cell immunotherapy
11:00 – 11:30 Coffee break with sandwich/pastry
11:30 – 11:45 Yasmin Yu, Karolinska Institutet – Sprint Bioscience Development of selective VPS34 inhibitors to modulate autophagy in tumors .
11:45 – 12:00 Matheus Dyczynski, Karolinska Institutet Targeting Vps34 improves chemosensitivity of triple negative breast cancer cells .
12:00 – 12:30 Michail Sitkovsky, Northeastern University, Boston Anti-Hypoxia/HIF-1alpha and anti-A2A-Adenosinergic Co-adjuvants to enable the rejection of the most therapy-resistant tumors
12:30 – 13:00 Pär Nordlund, Karolinska Institutet Protein biophysics to dissect cellular responses to cancer drugs
13:00 Concluding remarks
